unknown
Stage
About
Immunocodex develops tolerogenic mRNA vaccines designed to reprogram immune cells and restore immune balance for the treatment of autoimmune diseases.
Explore Immunocodex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.